As former CEOs, global leaders, and industry-leading specialists, Pasaca Capital leadership offers decades of experience and closes the gap between developed and developing economies. We are proud to skillfully guide organizations to profit and expand opportunities at the intersection of society and technology.
With experience across varied domains including finance, government, IT, and manufacturing, Pasaca Capital leaders possess the agility, financial acumen, resources, and extensive networks necessary to maximize startup asset value. The leadership team is passionate about realizing positive outcomes that serve greater society. Inspiring and ethically driven, their unique perspectives and understanding of emerging technologies, global economies, and political forces, enable successful integration with larger ecosystems, sustainable growth, and market traction.
Charles Huang, PhD
Areas of Expertise: Strategy and Investment Banking
Education: Ph.D. in Marketing and an MBA from the University of Strathclyde, Scotland. Bachelor’s in Economics from Wuhan University, China.
Bio: Charles is a former top analyst at HSBC securities, Credit Lyonnais Securities Asia and BNP Paribas. He predicted the eminent market crashes of Hong Kong and China A share markets near their peaks and called precisely at the bottom of Hong Kong market.
He played a key role in the strategic alliance between China’s Brilliance Group and MG Rover Group in the UK in 2002 and later co-founded Pan-Asia Environmental Technologies, which became a successful public company in December 2007 amid difficult market conditions.
Charles is also the Chairman of the Charles Huang Foundation, a philanthropic organization with a focus on education, medical research and entrepreneurship.
Sean E. Rogers
Areas of Expertise: Strategy, Marketing and Investment Banking
Education: B.A. in History and MBA from Vanderbilt University.
Bio: Sean joined Pasaca Capital in February of 2021. Previously, he was a Senior Investment Banker for 25 years and has been based in New York, Palo Alto and London. He was active advising clients, from Startups to Mega Caps, in capital formation and M&A. As Global Head of Technology Strategy & Solutions at Citigroup, he engaged clients across all industry verticals on tech enablement, digital disruption and transformation. Prior to his career in Investment Banking, Sean was in Sports Marketing and Brand Management at a Leading Consumer Packaged Goods Company. He sits on the Board of Visitors for Vanderbilt University’s Owen Graduate School of Management.
Areas of Expertise: Strategy, Sales and Marketing
Education: B.S. in mechanical engineering from California State University, Long Beach. B.S. in Environmental Management from Columbia Southern University.
Bio: Daniel Elliott is a recognized leader in business growth strategy across a diverse number of market sectors. Daniel has deep experience in identifying and commercializing leading edge technologies, corporate M&A transactions, capital investments, technology validation, successful strategic partnerships, operations and other key activities associated with business value growth.
Partner/Chief Legal Officer
Areas of Expertise: Corporate and Transactional Law
Education: Robert received his bachelor’s degree in Political Science from CSUSB and attended law school at the University of La Verne, College of Law.
Bio: As a licensed attorney in California and Texas, Robert has played a critical role in private and public start-ups, as well as mergers and acquisitions for both domestic and international clients.
Robert’s stellar career includes the acquisition of a private equity firm in Holland, a battery manufacturer in Germany, and now working closely with Innova Medical Group to build strategic partnerships in Europe, Asia, South America and the Middle East.
Yichen Lu, PhD
Executive Vice President
Areas of Expertise: Infectious Diseases, Vaccines, Business Development
Education: Ph.D. in Virology from Temple University, Pennsylvania. Bachelor of Science in Biochemistry from Nankai University, China.
Bio: Dr. Lu is an infectious disease expert who has spent more than 35 years in research institutions and private businesses focused on vaccine development. As EVP for Pasaca, Dr. Lu is responsible for vaccine business development. Dr. Lu also serves as Chairman of Hainan VTI Clinical Immunology Lab, and President and Chairman of Hainan VTI Bioengineering Development Company. Prior to that, he was CEO of Vaccine Technologies Inc (VTI) in Boston for more than 12 years. Earlier in his career, he served various research leadership roles in Harvard AIDS Institute, Virus Research Institute, Cambridge, Institute for International Vaccine Development, Cambridge and William Haseltine’s Lab at Dana Farber Cancer Institute, Harvard Medical School.
Dr. Lu published several books on infectious diseases, including the Handbook of Global Tuberculosis Control, HIV/AIDS Treatment in Resource Poor Countries and AIDS in Asia.
Darren J. Marino
Areas of Expertise: Corporate Development & Strategy, Transaction Sourcing and Execution
Education: Bachelor of Science in Commerce & Engineering from Drexel University. MBA from the University of Chicago Booth School of Business. Attended executive leadership programs at Harvard Business School and Kellogg School of Management.
Bio: Darren joined Pasaca Capital in September of 2019. He is an experienced private equity, corporate development, and finance executive responsible for completing numerous transactions exceeding $3 billion and strategic investment portfolio valued over $5 billion.
Prior to Pasaca, he was an officer, global corporate development for a technology Fortune 500 company and served on multiple boards. He also served adjunct faculty member at Drexel University’s LeBow College of Business with focus on experiential learning, entrepreneurship, and corporate venturing.
Areas of Expertise: Strategy, General Management and Business Development
Education: BSEE from Rensselaer Polytechnic Institute. MSEE from the University of Southern California where he was a Howard Hughes Fellow. MBA from Villanova.
Bio: Mark joined Pasaca Capital in May of 2020. He has successfully started up and operated a wide range of technology businesses, including a multi-billion dollar video and data network equipment business.
Mark has led several investments in technology startups, as well as a number of acquisitions and corporate integrations. He led the development of the world’s first viable digital cable system, which has won several Emmy Awards for technical achievement. He holds many patents in the areas of digital video technology and cybersecurity.
Areas of Expertise: International Business, Government Affairs and Corporate Management
Bio: James has over 30 years of experience in international business, government and public affairs, and corporate management. He has extensive experience working in partnership with several multinational companies, especially in telecommunications, advanced manufacturing, and high technology, including Fujitsu, Philips, NEC, and Siemens.
He led the team to introduce China’s first 10-thousand program-controlled telephone systems and facilitated its nationwide promotion, which signaled the opening up of China’s telecommunications industry. James also led his team to introduce the fiber optic cable to China from AT&T.
In recent years, James has founded Evergrande Investment and Silk Road Asset Management to bridge the technical and financial cooperation between Chinese companies and foreign institutions.
Areas of Expertise: Strategic Alliances, Corporate Strategies and European Markets
Bio: Goran has more than ten years of experience in strategic consulting. The industries of his clients span from IT, automotive, entertainment, new energy, clean-tech, transportation, and logistics. Goran also served as producer and executive producer for events and projects tied to space and space exploration and worked closely with the European Commission, Russian space agency, and the European space agency.
Goran has been a Partner of Pasaca Capital Inc. since 2017. Goran heads the Europe region for Pasaca Capital where he builds value by identifying opportunities that can be brought into other expanding economic regions that greatly benefit shareholders and investor returns.
Areas of Expertise: Finance, Securities and Asset Management
Education: Michelle received her Master’s of Business Administration from the Hong Kong University of Science and Technology
Bio: Early in her career, Michelle managed institutional and high-net-worth individual clients at Haitong International Securities. Michelle also worked for Standard Chartered Bank, BNP, Credit Suisse, and CLSA in various institutional sales roles. Michelle founded an assets management firm and a securities services firm and acted as
CEO, facilitating asset management applications and advising and dealing in securities at the Securities and Futures Commission. Michelle joined Pasaca Capital as a partner in 2017 bringing with her 16 years of experience in the financial industry.
Areas of Expertise: Stock Analysis, Market Projections and Business Development
Education: Derrick received his MBA from the University of Kentucky
Bio: Derrick has over three decades of experience in the banking and consulting sector. He started at Deloitte Consulting where he specialized in the healthcare and consumer sector for 15 years. He also acted as CEO of a biotech pharmaceutical company for nearly five years before joining BNP Paribas Asia as a healthcare analyst. Subsequently, Derrick was the manager of multiple public funds and designated NSSF fund at ICBC Credit Suisse Asset Management Company in Hong Kong.
With his seminal report on China’s forthcoming pharmaceutical sector in early 2009, Derrick became a ranked analyst in 2010 and remained a top “picker” in the sector for several years. All funds managed by Derrick during his career as a portfolio manager achieved significant and consistent success, outperforming their benchmarks.
Bringing unrivalled insight and connections into China’s healthcare industry, Derrick Sun joined Pasaca Capital Inc. in January 2021 and is a managing director of Innova Strategies Ltd., a wholly owned subsidiary of Pasaca Capital Inc.